Moderna Inc (MRNA)
107.97
+1.79
(+1.69%)
USD |
NASDAQ |
Apr 26, 16:00
107.80
-0.16
(-0.15%)
After-Hours: 20:00
Moderna Accounts Receivable (Quarterly): 892.00M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 892.00M |
September 30, 2023 | 1.866B |
June 30, 2023 | 232.00M |
March 31, 2023 | 1.113B |
December 31, 2022 | 1.385B |
September 30, 2022 | 2.695B |
June 30, 2022 | 2.691B |
March 31, 2022 | 3.173B |
December 31, 2021 | 3.175B |
September 30, 2021 | 3.142B |
June 30, 2021 | 2.02B |
March 31, 2021 | 3.22B |
Date | Value |
---|---|
December 31, 2020 | 1.391B |
September 30, 2020 | 203.44M |
June 30, 2020 | 50.34M |
March 31, 2020 | 10.50M |
December 31, 2019 | 9.462M |
September 30, 2019 | 18.12M |
June 30, 2019 | 10.83M |
March 31, 2019 | 17.95M |
December 31, 2018 | 22.67M |
September 30, 2018 | 11.56M |
December 31, 2017 | 15.16M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
9.462M
Minimum
Dec 2019
3.22B
Maximum
Mar 2021
1.437B
Average
1.385B
Median
Dec 2022
Accounts Receivable (Quarterly) Benchmarks
Eli Lilly and Co | 9.090B |
Merck & Co Inc | 10.35B |
Pfizer Inc | 11.18B |
Johnson & Johnson | 14.87B |
Novavax Inc | 297.24M |